Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prevail Therapeutics is a biotech company that is developing gene-therapy for brain disorders such as Parkinson's disease.

The research team are using the Data Portal to understand in more detail the natural history of the disease in terms of its genetics in order to: identify clinical endpoints and biomarkers that evolve with disease course in the most predictable fashion in longitudinal studies; define sub-populations of interest for closer study, and estimate the effect of changes to appropriately design clinical studies.